Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone.

@article{Itkonen2016ClopidogrelMI,
  title={Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone.},
  author={Matti K. Itkonen and Aleksi Tornio and Mikko Neuvonen and Pertti J Neuvonen and Mikko T. Niemi and Janne T. Backman},
  journal={Drug metabolism and disposition: the biological fate of chemicals},
  year={2016},
  volume={44 8},
  pages={
          1364-71
        }
}
The glucose-lowering drug pioglitazone undergoes hepatic CYP2C8-mediated biotransformation to its main metabolites. The antiplatelet drug clopidogrel is metabolized to clopidogrel acyl-β-d-glucuronide, which was recently found to be a strong time-dependent inhibitor of CYP2C8 in humans. Therefore, we studied the effect of clopidogrel on the pharmacokinetics of pioglitazone. In a randomized crossover study, 10 healthy volunteers ingested either 300 mg of clopidogrel on day 1, and 75 mg on days 2… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 8 times. VIEW TWEETS